Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amka Med is a medical device company focused on developing non-invasive treatments for obesity and metabolic diseases. The company was founded by Amir Belson, a prolific medical entrepreneur known for founding numerous successful medtech startups. Amka Med's core technology is a wearable intra-oral device designed to stimulate satiety and reduce appetite through controlled thermal modulation of the palate. This approach targets the neural signaling pathways between the oral cavity and the brain's appetite centers to promote weight loss. The device offers a potential alternative to invasive bariatric surgeries and long-term pharmacological treatments. Clinical feasibility studies have been conducted to evaluate the safety and efficacy of the device in patients with obesity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMKA Med.